P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA‐DIRECTED CAR‐T CELL THERAPY MANUFACTURED USING THE T‐CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)

Authors :: Sperling, A. S.
Nikiforow, S.
Derman, B.
Nadeem, O.
Mo, C.
Laubach, J.
Anderson, K.
Alonso, A.
Im, S.‐Y.
Ikwgawa, S.
Prabhala, R.
Hernandez Rodriduez, D.
Daley, H.
Shaw, K. L.
Arihara, Y.
Ansari, S.
Quinn, D. S.
Pearson, D.
Hack, A.
Treanor, L.
Source :: HemaSphere; 2022 Supplement 3, Vol. 6, p1329-1330, 2p
Publication Year :: 2022

Full Text Access

Tools